Navigation Links
Expression Injectable by Enhancement Medical – Adverse Events: AttorneyOne Monitors and Keeps Consumers Informed
Date:8/8/2014

San Diego, CA (PRWEB) August 08, 2014

AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Expression Injectable.

The FDA issued a safety communication on August 5, on adverse events associated with the unapproved use of the Expression product as a dermal filler. Expression is used as an intranasal splint, intended to minimize bleeding and swelling and to prevent adhesions between the septum and the nasal cavity.

FDA’s reason for the safety communication is that the Agency became aware of adverse events, related to unapproved use, that included itching, discoloration, redness, bruising, pain, bumps, lumps, firmness, tenderness, swelling, and the development of hard nodules.

Taking into consideration the latest developments, AttorneyOne.com monitor daily and update the website providing accurate information on all relevant FDA safety alerts. Sean Burke, director of Media Relations at AttorneyOne.com, adds, “We are determined to keep an eye on FDA announcements concerning Expression Injectable and inform the public. For that reason," he continues, "our focus should squarely fall on investigating these safety alerts and getting the word out.”

The FDA recommends that “health care providers stop using Expression by Enhancement Medical LLC as a subcutaneously administered substance and instead use the list of FDA approved fillers.” And the Agency adds “patients who have received treatment with Expression as a dermal filler should be monitored for adverse events and referred for corrective treatment when appropriate.”

AttorneyOne.com has further information on Expression Injectable at the website including latest major drug, food, and medical products law news.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/08/prweb12077689.htm.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12081219.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Barriers to obtaining gene expression profiling test heightened perceived value
2. Overexpression of Notch1 in temporal lobe epilepsy
3. TAG-1 induces apoptosisrelated gene expression without triggering glioma apoptosis
4. Shuganjieyu capsule increases neurotrophic factor expression in a rat model of depression
5. Variable gene expression in zebrafish
6. Occludin and connexin 43 expression in the pathogenesis of traumatic brain edema
7. Gene-expression-based biomarker predicts long-term risk of breast cancer recurrence
8. Researchers report a complete description of gene expression in the human retina
9. Advancement in Biologic Protein Expression Webinar Hosted by Selexis SA
10. Gene expression test distinguishes between breast cancer patients at high and low risk of late recurrence
11. McHugh Plastic Surgery & Secret Expressions Med Spa Offer Injection Day Specials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology: